UK Breast Cancer Diagnostics Market Size & Outlook
UK breast cancer diagnostics market, 2018-2030 (US$M)
Related Markets
UK breast cancer diagnostics market highlights
- The UK breast cancer diagnostics market generated a revenue of USD 630.4 million in 2023 and is expected to reach USD 1,128.0 million by 2030.
- The UK market is expected to grow at a CAGR of 8.7% from 2024 to 2030.
- In terms of segment, outpatient facilities was the largest revenue generating end use in 2023.
- Home Care is the most lucrative end use segment registering the fastest growth during the forecast period.
Breast cancer diagnostics market data book summary
| Market revenue in 2023 | USD 630.4 million |
| Market revenue in 2030 | USD 1,128.0 million |
| Growth rate | 8.7% (CAGR from 2023 to 2030) |
| Largest segment | Outpatient facilities |
| Fastest growing segment | Home Care |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
| Key market players worldwide | BD, Danaher Corp, Koninklijke Philips NV, Qiagen NV, Thermo Fisher Scientific Inc, Myriad Genetics Inc, Argon Medical Devices, Roche Holding AG ADR, Hologic Inc |
Other key industry trends
- In terms of revenue, UK accounted for 3.6% of the global breast cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany breast cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,128.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Cancer Diagnostics Market Scope
Breast Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK breast cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 61.12% in 2023. Horizon Databook has segmented the UK breast cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
In the UK, all medical needs are completely covered by NHS and an integrated health research system has been provided by the National Institute of Health Research (NIHR). The presence of sophisticated healthcare infrastructure, high disposable income, and growing awareness pertaining to early diagnosis of breast cancer are key drivers of breast cancer diagnostics market. Rising prevalence of breast cancer is expected to boost market growth.
As per the estimates of Breast Cancer Care published in 2019, approximately 370 men and 55,000 women were diagnosed with breast cancer in the UK. Furthermore, it was published that 8 out of 10 cases were diagnosed in women aged 50 and above. Demand for accurate and rapid diagnosis of breast cancer is increasing in the UK.
A panel of genetic tests has been prepared, which forms the basis of certain cancers. Furthermore, UKGTN has collaborated with NHS England for providing cost-effective genetic testing services. The abovementioned factors are expected to accelerate market growth in the country.
Reasons to subscribe to UK breast cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK breast cancer diagnostics market databook
-
Our clientele includes a mix of breast cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK breast cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UK breast cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK breast cancer diagnostics market size, by end use, 2018-2030 (US$M)
UK Breast Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
